Evidence map›Paper›PMID 41893942›Full record

ArticleHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2026

Cardiac Organ Damage in Young Adults with Cryptogenic Ischaemic Stroke: The SECRETO Study.

Rune Krogh Eilertsen, Eva Gerdts, Ulrike Waje-Andreassen, Dana Cramariuc, Rasmus Bach Sindre, Jani Pirinen, Satu Suihko, Tomi Sarkanen, Marko Virtanen, Essi Ryödi and 24 more

Abstract read
In one paragraph

Article in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Rune Krogh EilertsenDepartment of Clinical Science, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway. rune.eilertsen@uib.no.ORCID http://orcid.org/0009-0008-1249-5190
Eva GerdtsDepartment of Clinical Science, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.ORCID http://orcid.org/0000-0003-4109-2311
Ulrike Waje-AndreassenDepartment of Neurology, Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0003-3240-6040
Dana CramariucDepartment of Clinical Science, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.ORCID http://orcid.org/0000-0002-1593-2017
Rasmus Bach SindreDepartment of Clinical Science, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.ORCID http://orcid.org/0009-0001-2342-8849
Jani PirinenHeart and Lung Centre, Helsinki University Central Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0002-4030-9358
Satu SuihkoHeart and Lung Centre, Helsinki University Central Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0002-6873-2502
Tomi SarkanenDepartment of Neurology, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.ORCID http://orcid.org/0000-0001-8815-2807
Marko VirtanenHeart Hospital, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.ORCID http://orcid.org/0000-0001-9674-0772
Essi RyödiHeart Hospital, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
Pekka JäkäläNeurocenter Neurology, Kuopio University Hospital, Finland, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0002-8410-6915
Marja HedmanHeart Center, Kuopio University Hospital, Kuopio, Finland.ORCID http://orcid.org/0000-0003-1318-8287
Petra RedforsDepartment of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-5956-4255
Odd Bech-HanssenDepartment of Clinical Physiology, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-9572-9819
Juha HuhtakangasDepartment of Neurology, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID http://orcid.org/0000-0001-7143-519X
Pauli YlikotilaDepartment of Neurology, Turku University Hospital, University of Turku, Turku, Finland.ORCID http://orcid.org/0009-0002-4126-9666
Riikka LautamäkiHeart Center, Turku University Hospital, University of Turku, Turku, Finland.
Antti SarasteHeart Center, Turku University Hospital, University of Turku, Turku, Finland.
Bettina von SarnowskiDepartment of Neurology, University Medicine Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0002-1458-476X
Raila BuschDepartment of Internal Medicine B (Cardiology), University Medicine Greifswald, Greifswald, Germany.ORCID http://orcid.org/0009-0006-4676-3363
Ana Catarina FonsecaDepartment of Neurology, Hospital Santa Maria and Faculty of Medicine, University of Lisbon, Lisbon, Portugal.ORCID http://orcid.org/0000-0001-6913-5526
Ana G AlmeidaDepartment of Heart and Vessels, Hospital Santa Maria, CCUL@RISE, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.ORCID http://orcid.org/0000-0003-0360-4363
Patricia Martínez-SánchezDepartment of Neurology, Torrecardenas University Hospital, University of Almería, Almería, Spain.ORCID http://orcid.org/0000-0003-1945-4435
Janika KõrvDepartment of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0002-6074-0727
Piibe MudaDepartment of Clinical Physiology, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0009-0004-1363-4501
Phillip FerdinandUniversity Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.ORCID http://orcid.org/0000-0002-8715-2917
Cheryl OxleyCardiac Physiology Services, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
Diana ZakarkaitėInstitute of Clinical Medicine, Clinic of Cardiovascular Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.ORCID http://orcid.org/0000-0003-3299-7135
Kristina RyliškienėClinic of Neurology and Neurosurgery, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.ORCID http://orcid.org/0000-0001-9596-1733
Nicolas Martinez-MajanderDepartment of Neurology, Helsinki University Central Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0001-8489-7051
Juha SinisaloHeart and Lung Centre, Helsinki University Central Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0002-0169-5137
Jukka PutaalaDepartment of Neurology, Helsinki University Central Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0002-6630-6104
Helga MidtbøDepartment of Clinical Science, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway.ORCID http://orcid.org/0000-0002-3558-9914
SECRETO study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCardiac organ damage (OD) is associated with increased risk of cardiovascular disease. However, limited knowledge exists on cardiac OD in young patients with cryptogenic ischaemic stroke (CIS).

aimTo explore prevalence and covariates of cardiac OD in patients with CIS compared to controls participating in the SECRETO study.

methodsWe analysed data from 427 patients with CIS aged <50 years and 361 age- and sex-matched controls. OD was defined as presence of abnormal left ventricular (LV) geometry (LV hypertrophy or concentric remodelling) or left atrial enlargement (LAE) assessed by echocardiography, using sex-specific threshold values.

resultsCompared to controls, patients had higher prevalences of obesity and tobacco smoking, patent foramen ovale (PFO) (52% vs. 25%) and abnormal LV geometry (12% vs. 7%, all p < 0.01), while presence of LAE did not differ. In multivariable analyses, CIS was associated with presence of abnormal LV geometry (odds ratio 1.86 [95% confidence interval 1.09-3.20], p=0.024). In separate multivariable analyses in patients only, obesity was associated with both abnormal LV geometry and LAE (both p < 0.01), and higher systolic blood pressure only with presence of abnormal LV geometry (p < 0.001). No significant association with PFO was found.

conclusionIn young patients with CIS participating in the SECRETO study, abnormal LV geometry was more prevalent compared to age- and sex-matched controls and associated with presence of higher blood pressure and obesity. The results point to the importance of blood pressure and weight control in CIS to prevent progression of cardiac OD and recurrent cardiovascular events.

Indexed as

Hypertrophy, Left VentricularIschemic StrokeVentricular RemodelingAdultAge FactorsAtrial Function, LeftAtrial RemodelingBlood PressureCase-Control StudiesCross-Sectional StudiesEchocardiographyFemaleForamen Ovale, PatentHumansHypertensionMaleBlood pressureHypertensionIschaemic strokeObesityOrgan damage

Identifiers

PMID41893942
PMCPMC13283181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.